Next Article in Journal
Effects of Saccharomyces boulardii Supplementation on Nutritional Status, Fecal Parameters, Microbiota, and Mycobiota in Breeding Adult Dogs
Previous Article in Journal
Recombinant Ehrlichia canis GP19 Protein as a Promising Vaccine Prototype Providing a Protective Immune Response in a Mouse Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sphingolipidomics of Bovine Pink Eye: A Pilot Study

1
Metabolomics Unit, College of Veterinary Medicine, Lincoln Memorial University, 6965 Cumberland Gap Pkwy, Harrogate, TN 37752, USA
2
College of Veterinary Medicine, Lincoln Memorial University, 6965 Cumberland Gap Pkwy, Harrogate, TN 37752, USA
*
Author to whom correspondence should be addressed.
Vet. Sci. 2022, 9(8), 388; https://doi.org/10.3390/vetsci9080388
Submission received: 8 June 2022 / Revised: 26 July 2022 / Accepted: 26 July 2022 / Published: 28 July 2022
(This article belongs to the Section Veterinary Biomedical Sciences)

Abstract

:

Simple Summary

The liquid tear film, which protects the eye from the environment, is a dynamic fluid containing a large number of complex lipids. Disruptions of these lipids by infections can result in damage to the eye and ultimately blindness. In this study we characterized various lipid subfamilies present in the tear film of the eye and the effect of pink eye infections in cattle. Our findings demonstrate that the pink eye infections dramatically decrease the levels of lipids in the tear film covering the eye and suggest that this is a major factor in the development of blindness in infected cattle.

Abstract

Sphingolipids are essential structural components of tear film that protect the surface of the eye from dehydration. A detailed analysis of the effects of pink eye infections on the sphingolipidome in cattle has not previously been undertaken. We recently published a new assay utilizing high-resolution mass spectrometric monitoring of the chloride adducts of sphingolipids that provides enhanced sensitivity and specificity. Utilizing this assay, we monitored decreases in the levels of tear film ceramides with short-chain fatty acids, hydroxy-ceramides, phytoceramides, and hydroxy-phytoceramides. Dihydroceramide levels were unaltered and increased levels of ceramides with long-chain fatty acids (24:0 and 24:1) were monitored in cattle with pink eye. The data from this pilot study (n = 8 controls and 8 pink eye) demonstrate a major disruption of the lipid tear film layer in pink eye disease, that can result in severe eye irritation and damage.

1. Introduction

The tear film covering of the eye is structurally complex with 2 major layers: (1) an aqueous-mucin layer over the surface epithelium of the eye, which is secreted by surface epithelial cells and goblet cells and (2) an outer lipid layer composed of polar lipids which are secreted by the Meibomian glands, serving as the interface between the aqueous layer and the air [1,2,3].
The tear film is a dynamic structure protecting the eye surface from dehydration, physical abrasion from blinking, and provides immune protection against pollutants and pathogens. Tear film infections, like bovine pink eye, lead to a disruption of tear film stability by affecting the lipid components of the outer lipid layer and by inducing cytoprotective biochemical pathways [1,2,3].
Lipidomics analyses of the tear film have revealed that the lipid layer is extremely complex being composed of glycerophospholipids (diacyl and plasmalogens), lysophosphatidic acids, cyclic phosphatidic acids, sphingomyelins, fatty acids, fatty acyl esters of hydroxy-fatty acids (FAHFA), triglycerides, cholesterol esters, and wax esters [3,4,5,6]. In our previous lipidomics analyses of bovine pink eye [6], we monitored induction of anti-inflammatory lipids, including cyclic phosphatidic acids and resolvins. We also monitored increases in the levels of structural lipid components including FAHFAs (also termed o-acyl-hydroxy-fatty acids [6]), ethanolamine plasmalogens, and sphingomyelins.
However, our direct infusion assay was limited in sensitivity for a number of sphingolipids. Sphingolipids are important structural components of membranes and tear film, with hydroxy sphingolipids representing stabilizers due to their increased hydrogen bonding capabilities. Alterations in these hydroxy lipids can disrupt the tear film layer resulting in dehydration and abrasion to the eye. With these issues in mind, we undertook a more in-depth high-resolution mass spectrometric analysis of the tear film sphingolipidome utilizing a new assay of the chloride adducts of these lipids, which provides improved sensitivity and specificity [7,8].

2. Materials and Methods

2.1. Clinical Samples

A herd of approximately 1200 Black Angus cattle of various ages (0–15 years) were used in this study. The cattle were visually evaluated in groups of 70–100 at least every 30 days for active Infectious Bovine Keratoconjunctivitis (IBK). The prevalence rate of pink eye each spring in this herd is 25%. When active Stage 3 IBK infection was visually noted, samples were collected for lipidomics analyses. A picture of the IBK affected eye(s) was captured and a sample of ocular (tear) fluid was collected by placing 2 cotton tipped swabs in the lower eyelid. The cotton tipped swabs were placed in 1 mL of methanol and transported to the laboratory for analyses. Following sample collection, the affected animals were treated with tulathromycin or gamithromycin and an eye patch was applied to the severe cases. The pictures were evaluated to determine the Stage of the pinkeye infection as described by W.D. Whittier et al. (Supplementary Clinical Data). The veterinarian collecting the samples also staged the disease in each animal.

2.2. Lipidomics

To the cotton swabs in 1 mL of methanol were added 1 mL of water and 2 mL of methyl-tert-butyl ether. The tubes were next vigorously shaken at room temperature for 30 min. prior to centrifugation at 4000× g for 30 min. at room temp. The upper organic layer was isolated and dried by centrifugal vacuum evaporation. This protocol is identical to our previous publications [7,8] except for a modification in the composition of the infusion solution: 2-propanol: methanol: chloroform: H2O (160:80:80:1) with the water containing 15 mg of NH4Cl.
Direct infusion lipidomics utilized high-resolution data acquisition (≤1 ppm mass error), with an orbitrap mass spectrometer (Thermo Q Exactive). In negative ion ESI, the chloride adducts [7,8] of ceramides, dihydroceramides, hydroxy-ceramides, phytoceramides (Cer X-O3), and hydroxy-phytoceramides (Cer X-O4 and Cer X-O5) were reliably monitored (Supplementary Table S1). Hexosyl-ceramides, lactosyl ceramides, acyl-ceramides, deoxyceramides, and ceramide-phosphoethanolamines were not reliably detected. Between injections, the transfer line was washed with successive 500 µL washes of methanol and hexane/ethyl acetate/chloroform/H2O (3:2:1:0.1).
Validation of infection was also investigated with high-resolution mass spectrometric analysis of bacterial membrane trehalose monohydroxylcorynomycolates (hTMCM; [9]) in the tear film extracts.
Validation of the phytoceramides and hydroxyceramides as t18:0/X was achieved via tandem mass analyses with positive ESI. In all cases the double dehydrated cation of t18:0 (282.2792) was monitored as a product ion with <2 ppm mass error. For MS2 analyses, an isolation window of 0.4 amu and collision energies of 10, 20, and 30 NCE were used.

2.3. Statistical Analysis

Since the samples were absorbed onto cotton swabs for extraction, we had no index of the volume collected. Therefor standardization of the data, based on tear volume, was not possible. In this regard, we expressed the peak intensity of individual sphingolipids as a ratio to the peak intensity of endogenous Cer d18:1/16:0 in each tear film sample. This is a valid comparator since we have previously shown that Cer d18:1/16:0 levels are unaltered in pink eye infections [4]. The data presented in graphs are from a pilot study with 8 controls and 8 cattle with pink eye. A Student’s t-test (Microsoft Excel), assuming equal or unequal variances, was used to determine significant differences in relative levels of metabolites between pink eye animals and controls, subsequent to an F-test (Microsoft Excel) to determine if the variances between groups were statistically different.

3. Results

3.1. Clinical Samples

For the lipidomics analyses, 8 controls with no clinical signs of eye infections were selected for our pilot study along with 8 cattle with stage 3 pink eye infections.

3.2. Ceramides

The chloride adducts of 24 ceramides were reliably monitored. In Figure 1, we report the ceramides with a signal-to-noise ratio >5. The levels of ceramides with 18:0, 24:0, 26:0, and 28:0 fatty acid substituents were unaltered in the tear film of cattle infected with pink eye (Figure 1). In contrast, Cer d18:1/16:1 and Cer d18:1/18:1 were decreased, while Cer d18:1/22:0 and Cer d18:1/24:1 were augmented (Figure 1). Tear film ceramides have been reported previously to be decreased with meibomian gland dysfunction and parasitic infections [10,11,12,13]. This is important in that these sphingolipids are integral in maintaining the structural stability of the tear film which protects the ocular surface from abrasion, irritants and infections [10,11,12,13,14,15].

3.3. Hydroxy-Ceramides

The chloride adducts of 19 hydroxy-ceramides were reliably monitored. In Figure 2, we report the hydroxy-ceramides with a signal-to-noise ratio >5. Hydroxyceramides with short-chain 2-hydroxy fatty acid substituents were consistently decreased in the tear film of infected cattle (Figure 2). Control levels of hydroxy-ceramides were approximately 2 times the control levels of ceramides in bovine tear film (Figure 1). These lipids can be formed de novo by addition of a hydroxy fatty acid rather than a fatty acid or by lipid remodeling involving deacylation followed by reacylation with a hydroxy fatty acid. This is the first report, to-date, of hydroxy-ceramides in tear film. The greater hydrogen bonding capabilities of hydroxy-ceramides increases their ability to interface between the aqueous and lipid layers of tear film [16,17,18,19,20,21,22].

3.4. Phytoceramides (Cer X-O3)

The chloride adducts of 25 phytoceramides were reliably monitored. In Figure 3 we report the phytoceramides with a signal-to-noise ratio >5. The levels of tear film phytoceramides were consistently decreased in pink eye infections (Figure 3). Phytoceramides are generated by the addition of an additional hydroxy group (hence Cer X-O3) to the sphinganine base of a dihydroceramide and by direct synthesis from phytosphinganine. This is the first report, to-date, of phytoceramides in tear film. The greater hydrogen bonding capabilities of phytoceramides increases their ability to interface between the aqueous and lipid layers of tear film [16,17,18,19,20,21,22].

3.5. Hydroxy-Phytoceramides (Cer X-O4)

The chloride adducts of 22 hydroxy-phytoceramides (Cer-X-O4) were reliably monitored. In Figure 4 we report the Cer X-O4s with a signal-to-noise ratio >5. The levels of tear film Cer X-O4 lipids were all decreased in infected cattle (Figure 4). In this class of lipids, a 2-hydroxy fatty replaces the fatty acid substituent. This can take place via de novo biosynthesis or via lipid remodeling. This is the first report, to-date, of Cer X-O4s in tear film. The greater hydrogen bonding capabilities of these sphingolipids increases their ability to interface between the aqueous and lipid layers of tear film [16,17,18,19,20,21,22].

3.6. Hydroxy-Phytoceramides (Cer X-O5)

The chloride adducts of 11 hydroxy-phytoceramides (Cer X-O5) were reliably monitored. In Figure 5 we report the Cer X-05s with a signal-to-noise ratio >5. The diversity of tear film Cer X-O5 lipids (Figure 5) was dramatically less than our observations with Cer X-O3 (Figure 3) and Cer X-O4 (Figure 4) phytoceramides. In this class of lipids, replacement of the fatty acid with a dihydroxy fatty acid in the biosynthesis of phytoceramides occurs. For these lipids, only Cer 42:0-O5 and Cer 44:0-O5 were decreased (Figure 5). This is the first report, to-date, of Cer X-O5s in tear film. The greater hydrogen bonding capabilities of these sphingolipids increases their ability to interface between the aqueous and lipid layers of tear film [16,17,18,19,20,21,22].

3.7. Dihdroceramides

The chloride adducts of 8 dihydroceramides were reliably monitored. Of dihydroceramides with a signal-to-noise ratio >5, the tear film levels of dihydroceramides 16:0, 18:0, 20:0, 22:0 and 24:0 were unaltered with pink eye. Dihydroceramides are the direct precursors of both ceramides and phytoceramides.

3.8. Biomarkers of Ocular Infection

The chloride adducts of 3 bacterial membrane trehalose monohydroxylcorynomyclates [9] were reliably monitored in the tear film of cattle with pink eye and were absent from control cows (Table 1). These complex bacterial membrane saccharolipids are composed of a long-chain hydroxy fatty acid with an acyl linkage to the disaccharide, trehalose. The levels of trehalose monohydroxylcorynomyclates were low but detectable with a signal to noise of greater than 5. The monitored trehalose monohydroxylcorynomyclates are precursors of mycolic acids, virulence factors of bacteria [9]. We presume that in our study they are biomarkers of Moraxella bovis, the most frequent bacteria responsible for most pink eye infections.

4. Discussion

Previous studies, like this study, have demonstrated a diversity of ceramides in tear film [10,11,12,13], with decrements of these lipids in dry eye [11,12] and in eye infections with the ectoparasite desmodex [13]. These published data and our observations suggest that there are significant decrements in tear film ceramides with infection and meibomian gland dysfunction. Ceramides are polar lipids that interface between the outer non-polar lipids and the inner polar lipid layer that is associated with the inner aqueous phase, acting to stabilize the tear film [14,15]. It has been hypothesized that the hydrogen bonding properties of the head groups of these lipids contribute to maintaining the tear film structure [14,15].
While previous investigators have studied ceramides, hexosylceramides and sphingomyelins in tear film, they have not reported on the multiple hydroxy forms of sphingolipids [3,4,5]. Of particular interest are hydroxy-sphingolipids since these lipids are capable of enhanced hydrogen bonding [16]. Two major hydroxylation patterns are present in most biological systems. Namely hydroxylation of the sphingolipid base or of the fatty acid substituent. Sphinganine monooxygenase [17], (EC 1.14.18.5) introduces a hydroxy group into the sphingolipid base of sphinganine to generate phytosphingosine and into the sphingolipid base of dihydroceramides to generate phytosphingosines (Figure 6). Phytosphingosines can also be formed via direct hydroxylation of the sphingolipid base of dihydroceramides, catalyzed by dihydroceramide hydroxylase [18], (DES2). De novo generation of 2-hydroxy-phytoceramides is catalyzed by a large family of ceramide synthases [19], (CERS; 2-hydroxy fatty acid CoA + sphingolipid base → hydroxy-phytoceramide) and by direct hydroxylation of a phytoceramide via ceramide fatty acyl 2-hydroxylase [20,21,22], (FA2H). CERS can also generate 2-hydroxyceramides by addition of a 2-hydroxy fatty acid CoA to sphingosine (Figure 6). Conversion of sphingosine to ceramides and to hydroxyceramides is also catalyzed by the CERS family of enzymes (Figure 6). Omega-hydroxyceramides have also been reported in the literature [23]; however, these lipids are covalently bound to cellular membrane proteins via the ω-hydroxy group and are not extracted without prior hydrolysis steps.
Since we found no alterations in the levels of tear film dihydroceramides but decrements in ceramides, hydroxyceramides, phytoceramides and hydroxy-phytoceramides, the SURS, CERS, DES2, and FA2H enzyme systems must be dysfunctional in bovine pink eye infections. These deficiencies will ultimately result in increased shear forces on the surface of the eye and increased risk of dehydration. In addition, these lipids may function in an antimicrobial role to protect the eye [24,25], such that their decrements may accelerate microbial proliferation.
The ocular tear film is a 3 to 10 µm layer with an outer non-polar lipid layer and an inner polar lipid layer that interfaces with the aqueous layer covering the eye surface [14,15,16,17,18]. Tear film flows continuously to clear environmental debris and pathogens [20,21,22,23,24,25]. The lipid layers slow evaporation from the aqueous layer thereby protecting the eye surface from abrasion, pathogens, and inflammation. Hence, the structural integrity of tear film lipids is essential to maintain ocular function. The interphase of the aqueous and polar lipid layers is made possible by a number of amphiphilic lipids [2,3,6] and by polar lipids with hydroxy-fatty acid substituents. The hydroxy fatty acids provide enhanced hydrogen bonding with the aqueous film. Our study is the first to demonstrate that hydroxyceramides and hydroxyphytoceramides are present in tear film and are strong candidates for stabilizing the lipid-aqueous interface in tear film. Furthermore, disruption of these lipids in pink eye infections will be a major factor in the decline of ocular function in infected cattle.

5. Limitations and Future Directions

This was a pilot study with a small sample size therefore requiring a validation study in a larger population of cattle. We are currently collecting a larger sample set to address this issue, to monitor the time course of lipid changes, and to monitor lipid responses to antibiotic treatment.

6. Conclusions

This is the first report demonstrating the presence of hydroxyceramides, phytoceramides, and hydroxy-phytoceramides in tear film. As a result of the interconnected pathways in the generation and metabolism of hydroxy sphingolipids, a detailed pathway analysis cannot be generated until a number of the key enzymes have been quantitated. The decrements in a number of these hydroxy sphingolipids results in eye dehydration and possibly decreased antimicrobial protection.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vetsci9080388/s1, Table S1: Lipid masses.

Author Contributions

P.L.W. and L.M.J.M. both contributed to the conceptualization, methodology, formal analysis, investigation, and resources of this study. P.L.W. provided the software, performed the formal analysis and data validation, and prepared the original manuscript draft. Both authors have reviewed and proofed the draft. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Lincoln Memorial University.

Institutional Review Board Statement

The Lincoln Memorial University IRB approval for this study was 1809-CLIN.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Raw data files are available to qualified investigators.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pflugfelder, S.C.; Stern, M.E. Biological functions of tear film. Exp. Eye Res. 2020, 97, 108115. [Google Scholar] [CrossRef]
  2. Cwiklik, L. Tear film lipid layer: A molecular level view. Biochim. Biophys. Acta 2016, 1858, 2421–2430. [Google Scholar] [CrossRef] [PubMed]
  3. Khanna, R.K.; Catanese, S.; Emond, P.; Corcia, P.; Blasco, H.; Pisella, P.J. Metabolomics and lipidomics approaches in human tears: A systematic review. Surv. Ophthalmol. 2022, 67, 1229–1243. [Google Scholar] [CrossRef]
  4. Wood, P.L.; Donohue, M.N.; Cebak, J.E.; Beckmann, T.G.; Treece, M.; Johnson, J.W.; Miller, L.M.J. Tear film amphiphilic and anti-inflammatory lipids in bovine pink eye. Metabolites 2018, 8, 81. [Google Scholar] [CrossRef] [Green Version]
  5. Chen, J.; Green-Church, K.B.; Nichols, K.K. Shotgun lipidomic analysis of human meibomian gland secretions with electrospray ionization tandem mass spectrometry. Investig. Ophthalmol. Vis. Sci. 2010, 51, 6220–6231. [Google Scholar] [CrossRef] [PubMed]
  6. Wood, P.L. Fatty acyl esters of hydroxy fatty acid (FAHFA) lipid families. Metabolites 2020, 10, 512. [Google Scholar] [CrossRef]
  7. Wood, P.L.; Woltjer, R.L. Electrospray Ionization High Resolution Mass Spectrometry of the Chloride Adducts of Steroids, Mono- and Oligo-Saccharides, Xyloglucans, Ceramides, Gangliosides, and Phenols. In Springer Protocols, Neuromethods: Metabolomics; Wood, P.L., Ed.; Human Press: New York, NY, USA, 2021; Volume 159, pp. 69–76. ISBN1 978-1-0716-0863-0. ISBN2 eBook 978-1-0716-0864-7. [Google Scholar]
  8. Wood, P.L.; Hauther, K.A.; Scarborough, J.H.; Craney, D.J.; Dudzik, B.; Cebak, J.E.; Woltjer, R.L. Human brain lipidomics: Utilities of chloride adducts in flow injection analysis. Life 2021, 11, 403. [Google Scholar] [CrossRef] [PubMed]
  9. Klatt, S.; Brammananth, R.; O’Callaghan, S.; Kouremenos, K.A.; Tull, D.; Crellin, P.K.; Coppel, R.L.; McConville, M.J. Identification of novel lipid modifications and intermembrane dynamics in Corynebacterium glutamicum using high-resolution mass spectrometry. J. Lipid Res. 2018, 59, 1190–1204. [Google Scholar] [CrossRef] [Green Version]
  10. Shine, W.E.; McCulley, J.P. Polar lipids in human meibomian gland secretions. Curr. Eye Res. 2003, 26, 89–94. [Google Scholar] [CrossRef]
  11. Galor, A.; Sanchez, V.; Jensen, A.; Burton, M.; Maus, K.; Stephenson, D.; Chalfant, C.; Mandal, N. Meibum sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids. Ocul. Surf. 2022, 23, 87–95. [Google Scholar] [CrossRef]
  12. Paranjpe, V.; Tan, J.; Nguyen, J.; Lee, J.; Allegood, J.; Galor, A.; Mandal, N. Clinical signs of meibomian gland dysfunction (MGD) are associated with changes in meibum sphingolipid composition. Ocul. Surf. 2019, 17, 318–326. [Google Scholar] [CrossRef] [PubMed]
  13. Gao, H.; Chen, H.; Xie, H.T.; Xu, K.K.; Shi, B.J.; Huang, Y.K. Changes in meibum lipid composition with ocular demodex infestation. Transl. Vis. Sci. Technol. 2021, 10, 6. [Google Scholar] [CrossRef] [PubMed]
  14. Olżyńska, A.; Cwiklik, L. Behavior of sphingomyelin and ceramide in a tear film lipid layer model. Ann. Anat. 2017, 210, 128–134. [Google Scholar] [CrossRef] [PubMed]
  15. Patterson, M.; Vogel, H.J.; Prenner, E.J. The effect of repeated lateral compression and expansions mimicking blinking on selected tear film polar lipid monofilms. Biochim. Biophys. Acta Biomembr. 2017, 1859, 319–330. [Google Scholar] [CrossRef] [PubMed]
  16. Marquês, J.T.; Marinho, H.S.; de Almeida, R.F.M. Sphingolipid hydroxylation in mammals, yeast and plants—An integrated view. Prog. Lipid Res. 2018, 71, 18–42. [Google Scholar] [CrossRef]
  17. Mizutani, Y.; Kihara, A.; Igarashi, Y. Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation. FEBS Lett. 2004, 563, 93–97. [Google Scholar] [CrossRef]
  18. Enomoto, A.; Omae, F.; Miyazaki, M.; Kozutsumi, Y.; Yubisui, T.; Suzuki, A. Dihydroceramide: Sphinganine C-4-hydroxylation requires Des2 hydroxylase and the membrane form of cytochrome b5. Biochem. J. 2006, 397, 289–295. [Google Scholar] [CrossRef] [Green Version]
  19. Mizutani, Y.; Kihara, A.; Chiba, H.; Tojo, H.; Igarashi, Y. 2-hydroxy-ceramide synthesis by ceramide synthase family: Enzymatic basis for the preference of FA chain length. J. Lipid Res. 2008, 49, 2356–2364. [Google Scholar] [CrossRef] [Green Version]
  20. Alderson, N.L.; Rembiesa, B.M.; Walla, M.D.; Bielawska, A.; Bielawski, J.; Hama, H. The human FA2H gene encodes a fatty acid 2-hydroxylase. J. Biol. Chem. 2004, 279, 48562–48568. [Google Scholar] [CrossRef] [Green Version]
  21. Hama, H. Fatty acid 2-hydroxylation in mammalian sphingolipid biology. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2010, 1801, 405–414. [Google Scholar] [CrossRef] [Green Version]
  22. Maldonado, E.N.; Alderson, N.L.; Monje, P.V.; Wood, P.M.; Hama, H. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin. J. Lipid Res. 2008, 49, 153–161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Stewart, M.E.; Downing, D.T. The omega-hydroxyceramides of pig epidermis are attached to corneocytes solely through omega-hydroxyl groups. J. Lipid Res. 2001, 42, 1105–1110. [Google Scholar] [CrossRef]
  24. Wertz, P.W. Lipids and the permeability and antimicrobial barriers of the skin. J. Lipids 2018, 2018, 5954034. [Google Scholar] [CrossRef] [Green Version]
  25. Mudgil, P. Antimicrobial tear lipids in the ocular surface defense. Front. Cell. Infect. Microbiol. 2022, 12, 866900. [Google Scholar] [CrossRef]
Figure 1. Tear film levels of ceramides (Cer d18:1/x) in controls and cows with pink eye (P. Eye). The peak intensities of individual ceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 16:1 (0.013); 18:1 (0.021); 22:0 (0.027); 24:1 (0.039).
Figure 1. Tear film levels of ceramides (Cer d18:1/x) in controls and cows with pink eye (P. Eye). The peak intensities of individual ceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 16:1 (0.013); 18:1 (0.021); 22:0 (0.027); 24:1 (0.039).
Vetsci 09 00388 g001
Figure 2. Tear film levels of hydroxy-ceramides (Hydroxy-Cer d18:1/x) in controls and cows with pink eye (P. Eye). The peak intensities of individual hydroxy-ceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 16:0 (0.023); 18:0 (0.014); 18:1 (0.020); 20:1 (0.0083).
Figure 2. Tear film levels of hydroxy-ceramides (Hydroxy-Cer d18:1/x) in controls and cows with pink eye (P. Eye). The peak intensities of individual hydroxy-ceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 16:0 (0.023); 18:0 (0.014); 18:1 (0.020); 20:1 (0.0083).
Vetsci 09 00388 g002
Figure 3. Tear film levels of phytoceramides (Phyto-Cer) in controls and cows with pink eye (P. Eye). The peak intensities of individual phytoceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 34:0-O3 (0.024), 36:0-O3 (0.016), 36:1-O3 (0.01), 38:0-O3 (0.011), 40:0-O3 (0.040), 42:0-O3 (0.043), 44:0-O3 (0.036), 46:0-O3 (0.012), 46:1-O3 (0.034), 48:0-O3 (0.0086), and 48:1-O3 (0.026).
Figure 3. Tear film levels of phytoceramides (Phyto-Cer) in controls and cows with pink eye (P. Eye). The peak intensities of individual phytoceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 34:0-O3 (0.024), 36:0-O3 (0.016), 36:1-O3 (0.01), 38:0-O3 (0.011), 40:0-O3 (0.040), 42:0-O3 (0.043), 44:0-O3 (0.036), 46:0-O3 (0.012), 46:1-O3 (0.034), 48:0-O3 (0.0086), and 48:1-O3 (0.026).
Vetsci 09 00388 g003
Figure 4. Tear film levels of hydroxy-phytoceramides (CerX-O4) in controls and cows with pink eye (P. Eye). The peak intensities of individual hydroxy-phytoceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 38:0-O4 (0.0064), 40:0-O4 (0.0056), 40:1-O4 (0.0070), 42:0-O4 (0.0075), 42:1-O4 (0.0048), 44:0-O4 (0.013), 44:1-O4 (0.015), 46:0-O4 (0.0030), 48:0-O4 (0.10), and 48:1-O4 (0.018).
Figure 4. Tear film levels of hydroxy-phytoceramides (CerX-O4) in controls and cows with pink eye (P. Eye). The peak intensities of individual hydroxy-phytoceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 38:0-O4 (0.0064), 40:0-O4 (0.0056), 40:1-O4 (0.0070), 42:0-O4 (0.0075), 42:1-O4 (0.0048), 44:0-O4 (0.013), 44:1-O4 (0.015), 46:0-O4 (0.0030), 48:0-O4 (0.10), and 48:1-O4 (0.018).
Vetsci 09 00388 g004
Figure 5. Tear film levels of di-hydroxy-phytoceramides (CerX-O5) in controls and cows with pink eye (P. Eye). The peak intensities of individual di-hydroxy-phytoceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 42:0-O5 (0.021) and 44:0-O5 (0.0090).
Figure 5. Tear film levels of di-hydroxy-phytoceramides (CerX-O5) in controls and cows with pink eye (P. Eye). The peak intensities of individual di-hydroxy-phytoceramides are expressed as a ratio of the peak intensity of ceramide d18:1/16:0. *, significant t-test statistics: 42:0-O5 (0.021) and 44:0-O5 (0.0090).
Vetsci 09 00388 g005
Figure 6. Schematic of sphingolipid metabolism. Hydroxylation of free sphingolipid bases is catalyzed by monooxygenases (SUR2) and of sphingolipid bases in dihydroceramides via hydroxylases (DES2). The introduction of hydroxylation at position 2 of the fatty acid substituents of ceramides occurs via de novo synthesis with a hydroxy fatty acid (CERS, ceramide synthase) and via lipid modification by ceramide fatty acyl 2-hydroxylase (FA2H; phytoceramide → 2-hydroxy-phytoceramide).
Figure 6. Schematic of sphingolipid metabolism. Hydroxylation of free sphingolipid bases is catalyzed by monooxygenases (SUR2) and of sphingolipid bases in dihydroceramides via hydroxylases (DES2). The introduction of hydroxylation at position 2 of the fatty acid substituents of ceramides occurs via de novo synthesis with a hydroxy fatty acid (CERS, ceramide synthase) and via lipid modification by ceramide fatty acyl 2-hydroxylase (FA2H; phytoceramide → 2-hydroxy-phytoceramide).
Vetsci 09 00388 g006
Table 1. The chloride adducts of bacterial membrane trehalose monohydroxylcorynomyclates monitored in the tear film of cattle with pink eye.
Table 1. The chloride adducts of bacterial membrane trehalose monohydroxylcorynomyclates monitored in the tear film of cattle with pink eye.
LipidExact Mass[M+Cl]Level Relative to Cer d18:1/16:0ppm
hTMCM 28:2760.4973795.46710.0051 ± 0.00150.44
hTMCN 33:3828.5599863.52970.010 ± 0.00151.5
hTMCM 34:3842.5755877.54540.0070 ± 0.00231.3
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wood, P.L.; Miller, L.M.J. Sphingolipidomics of Bovine Pink Eye: A Pilot Study. Vet. Sci. 2022, 9, 388. https://doi.org/10.3390/vetsci9080388

AMA Style

Wood PL, Miller LMJ. Sphingolipidomics of Bovine Pink Eye: A Pilot Study. Veterinary Sciences. 2022; 9(8):388. https://doi.org/10.3390/vetsci9080388

Chicago/Turabian Style

Wood, Paul L., and Lynda M. J. Miller. 2022. "Sphingolipidomics of Bovine Pink Eye: A Pilot Study" Veterinary Sciences 9, no. 8: 388. https://doi.org/10.3390/vetsci9080388

APA Style

Wood, P. L., & Miller, L. M. J. (2022). Sphingolipidomics of Bovine Pink Eye: A Pilot Study. Veterinary Sciences, 9(8), 388. https://doi.org/10.3390/vetsci9080388

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop